Author:
Lin Yan,Guo Hong-Cheng,Kuang Yi,Shang Zhan-Peng,Li Bin,Chen Kuan,Xu Lu-Lu,Qiao Xue,Liang Hong,Ye Min
Funder
National Natural Science Foundation of China
National Mega-project for Innovative Drugs
Beijing Natural Science Foundation
Subject
Drug Discovery,Pharmacology,General Medicine
Reference33 articles.
1. Pharmacopoeia of the Peopleʼs Republic of China;Chinese Pharmacopoeia Commission,2010
2. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy;Li;J. Med. Chem.,2009
3. A unified strategy for the syntheses of the isoquinoline alkaloids berberine, coptisine, and jatrorrhizine;Mori-Quiroz;Org. Lett.,2018
4. Coptidis rhizome and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity;Meng;Chin. Med.,2018
5. Anti-Alzheimer’s potential of berberine using surface decorated multi-walled carbon nanotubes: a preclinical evidence;Lohan;Int. J. Pharm.,2017